Your browser doesn't support javascript.
loading
Aberrant inflammatory responses to type I interferon in STAT2 or IRF9 deficiency.
Gothe, Florian; Stremenova Spegarova, Jarmila; Hatton, Catherine F; Griffin, Helen; Sargent, Thomas; Cowley, Sally A; James, William; Roppelt, Anna; Shcherbina, Anna; Hauck, Fabian; Reyburn, Hugh T; Duncan, Christopher J A; Hambleton, Sophie.
Afiliación
  • Gothe F; Immunity and Inflammation Theme, Translational and Clinical Research Institute, Newcastle University, Newcastle, United Kingdom; Department of Pediatrics, Dr von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany.
  • Stremenova Spegarova J; Immunity and Inflammation Theme, Translational and Clinical Research Institute, Newcastle University, Newcastle, United Kingdom.
  • Hatton CF; Immunity and Inflammation Theme, Translational and Clinical Research Institute, Newcastle University, Newcastle, United Kingdom.
  • Griffin H; Immunity and Inflammation Theme, Translational and Clinical Research Institute, Newcastle University, Newcastle, United Kingdom.
  • Sargent T; Immunity and Inflammation Theme, Translational and Clinical Research Institute, Newcastle University, Newcastle, United Kingdom.
  • Cowley SA; James & Lillian Martin Centre for Stem Cell Research, Sir William Dunn School of Pathology, Oxford University, Oxford, United Kingdom.
  • James W; James & Lillian Martin Centre for Stem Cell Research, Sir William Dunn School of Pathology, Oxford University, Oxford, United Kingdom.
  • Roppelt A; Department of Immunology, Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
  • Shcherbina A; Department of Immunology, Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
  • Hauck F; Department of Pediatrics, Dr von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany.
  • Reyburn HT; Department of Immunology and Oncology, Spanish Center for Biotechnology (CNB-CSIC), Madrid, Spain.
  • Duncan CJA; Immunity and Inflammation Theme, Translational and Clinical Research Institute, Newcastle University, Newcastle, United Kingdom; Infection and Tropical Medicine, Royal Victoria Infirmary, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom. Electronic address:
  • Hambleton S; Immunity and Inflammation Theme, Translational and Clinical Research Institute, Newcastle University, Newcastle, United Kingdom; Children's Immunology Service, Great North Children's Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom. Electronic add
J Allergy Clin Immunol ; 150(4): 955-964.e16, 2022 10.
Article en En | MEDLINE | ID: mdl-35182547
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Interferón Tipo I Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Allergy Clin Immunol Año: 2022 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Interferón Tipo I Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Allergy Clin Immunol Año: 2022 Tipo del documento: Article País de afiliación: Alemania